Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Cancer Research|August 24, 2016
Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and CrossprimingMaría E Rodriguez-Ruiz, Inmaculada Rodriguez, Saray Garasa, et al.
Journal for Immunotherapy of Cancer|November 26, 2021
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacyMaite Alvarez, Carmen Molina, Carlos E De Andrea, et al.
Osteoarthritis and Cartilage|October 8, 2022
WWP2 confers risk to osteoarthritis by affecting cartilage matrix deposition via hypoxia associated genesM Tuerlings, G M C Janssen, I Boone, et al.
Cancer Research|June 27, 2015
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient MiceMiguel F Sanmamed, Inmaculada Rodriguez, Kurt A Schalper, et al.
Journal for Immunotherapy of Cancer|August 30, 2024
NKG2C/<i>KLRC2</i> tumor cell expression enhances immunotherapeutic efficacy against glioblastomaOlaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.
JAMA|November 2, 2021
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical TrialJulia A Bielicki, Wolfgang Stöhr, Sam Barratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2017
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patientsM F Sanmamed, J L Perez-Gracia, K A Schalper, et al.
Journal for Immunotherapy of Cancer|February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor modelsEneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Epilepsy Currents|December 25, 2025
Annual Course / From Then to Now: The Evolving Spectrum of Epilepsy CareHeather Ravvin McKee, Adriana Bermeo Ovalle, Luciana Giambarberi, et al.
Molecular Cancer|March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancerAntonin Levy, Daphné Morel, Matthieu Texier, et al.
Pageof 20